Epo Biomarkers Market is increasingly gaining rapid traction with rising cases of cancer and ESRD in the U.S.
Erythropoietin (Epo) protein is a naturally occurring hormone that can be found in the egg and in various other animal species. This hormone has been proven to increase red blood cell production. This is a very powerful growth factor and has shown promise in many areas of medical research. One of the key reasons for the increased adoption of EPO biomarkers is rising prevalence of end-stage renal disorders (ESRD). In fact, in 2017, there were around 124,500 new cases of registered ESRD as per the U.S. Renal Data System 2019 Annual Data Report. Such a high proportion of cases has necessitated the adoption of epo biomarkers for the diagnosis of ESRD. Furthermore, epo biomarkers can aid in the early detection of the disease, thereby making the treatment more effective and efficient. Hence, such factors can stimulate growth of the epo biomarkers market. Erythropoietin proteins are used in many medical applications and are useful for many years to come. It is a natural protein that c...